Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2023 06:59 ET | Source: The Insight Partners

Plant-based Vaccines Market Size to Hit 12.9% CAGR, Globally, by 2028 - Exclusive Report by The Insight Partners

Pune, India, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Plants are an important source to produce cost-effective vaccine derivatives. Plant-based vaccines can be made in a cost-effective way and produced on...
November 19, 2018 16:22 ET | Source: Emergent BioSolutions

Emergent BioSolutions and Valneva Report Positive Phase 1 Results for Their Vaccine Candidate Against the Zika Virus

GAITHERSBURG, Md. and SAINT-HERBLAIN, France, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) and Valneva SE (VLA) today announced positive interim results for the Phase 1...
November 05, 2018 10:04 ET | Source: GeoVax, Inc.

New Study Suggests Zika Virus Eradication in the Americas May Become Impossible, Making the Need for a Vaccine Even More Critical

GeoVax Comments on New Study Conducted in Brazil ATLANTA, GA, Nov. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...
August 22, 2018 09:00 ET | Source: BioBridge Global

QualTex Laboratories Implements New Zika Testing Guidance from U.S. Food and Drug Administration

San Antonio, Aug. 22, 2018 (GLOBE NEWSWIRE) -- QualTex Laboratories is up and running with new guidance for testing blood donations for the Zika virus, just weeks after the Food and Drug...
July 31, 2018 16:30 ET | Source: Emergent BioSolutions

Emergent BioSolutions Initiates Phase 1 Clinical Study of Zika Virus Immune Globulin Therapeutic

ZIKV-IG granted Fast Track designation by the U.S. Food and Drug Administration GAITHERSBURG, Md., July 31, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the...
June 12, 2018 08:30 ET | Source: Spotlight Innovation Inc.

Article Co-authored by Spotlight Innovation Research Collaborator Describes Small Molecule Drugs with In-vivo Efficacy Against Zika Virus Infection

URBANDALE, IA, June 12, 2018 (GLOBE NEWSWIRE) -- Spotlight Innovation Inc. (OTCQB: STLT), a pharmaceutical company targeting rare, emerging and neglected diseases, today announced that Company...
August 02, 2016 08:30 ET | Source: PositiveID Corporation

PositiveID Adds GenArraytion CEO R. Paul Schaudies, Ph.D. to its Board of Advisors

DELRAY BEACH, Fla., Aug. 02, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today...
March 31, 2016 14:05 ET | Source: Purdue Research Foundation

Zika virus discovery marks success of Purdue life sciences investment

West Lafayette, Ind., March 31, 2016 (GLOBE NEWSWIRE) -- Note to Journalists: A gallery of photos related to this news is available...
March 07, 2016 09:18 ET | Source: Phoenix Marketing International

New Research from Phoenix Marketing's Mobile Experience Platform, mXP, Reveals that Women of Childbearing Age are No More Concerned about Zika Virus than Men

RHINEBECK, N.Y., March 7, 2016 (GLOBE NEWSWIRE) -- Phoenix Marketing International (http://phoenixmi.com/), a global marketing research firm, today revealed new insights from the company's mobile...
February 29, 2016 10:02 ET | Source: Kline & Company

Mosquito Control Insecticides Market is Forecast to Spike Driven by the Zika Threat, According to Kline

PARSIPPANY, N.J., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Consumption of insecticides by professional mosquito control districts, which exhibits slower growth of 1.2% in 2015 over 2012, is forecast to spike...